FDA Drug Application (021988) for Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets by STRIDES ACROLAB

Back to FDA Applications sponsored by STRIDES ACROLAB

Application Number021988
Product Number001
FormTABLET; ORAL
Dosage150MG; 300MG; 200MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets
Active IngredientLAMIVUDINE; ZIDOVUDINE; NEVIRAPINE



Back to FDA Applications sponsored by STRIDES ACROLAB

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.